TRV
BLUE

Third Rock Ventures’s bluebird bio BLUE Stock Holding History

Third Rock Ventures’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-93,802
Closed -$111M – 6
2014
Q4 		$111M Hold
93,802
– – 9.11% 4
2014
Q3 		$43.6M Sell
93,802
-92,788
-50% -$42.8M 5.09% 6
2014
Q2 		$93.2M Hold
186,590
– – 19.9% 3
2014
Q1 		$55M Sell
186,590
-69,249
-27% -$21M 9.74% 4
2013
Q4 		$78.9M Buy
+255,839
New +$71.5M 22.36% 3

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Third Rock Ventures's BLUE Position: Q1 2015 in Review

Third Rock Ventures sold out of bluebird bio (BLUE) in Q1 2015, closing a stake of 93,802 shares — an estimated $111M sold.

Third Rock Ventures first reported a position in BLUE in Q4 2013 and held it in 5 quarters. The position peaked at $111M in Q4 2014. 210 funds tracked by Wall St. Rank hold BLUE as of Q1 2015.

  • Third Rock Ventures reported no remaining bluebird bio position as of Q1 2015 after selling out during the quarter.
  • Third Rock Ventures sold 93,802 bluebird bio shares in Q1 2015, an estimated $111M.
  • Third Rock Ventures first reported a position in bluebird bio in Q4 2013 and held it in 5 quarters.
  • Third Rock Ventures's bluebird bio position peaked at $111M in Q4 2014.
  • 210 funds tracked by Wall St. Rank held bluebird bio as of Q1 2015.

Based on Third Rock Ventures's 13F filing for Q1 2015, filed 29 Apr 2015.